Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous CINRYZE with rHuPH20 for HAE Prevention
NCT01756157Phase 2Completed
- Sponsor
- Takeda
- Start
- Feb 2013
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Takeda. Started Feb 2013; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT01756157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756157.